These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29664027)

  • 1. Mycobacteria-derived biomarkers for tuberculosis diagnosis.
    Druszczynska M; Wawrocki S; Szewczyk R; Rudnicka W
    Indian J Med Res; 2017 Dec; 146(6):700-707. PubMed ID: 29664027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
    Marimani M; Ahmad A; Duse A
    Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the past, a long way to future challenges for a greater control of tuberculosis.
    Villa S; Riccardi N; Canetti D; Alagna R; Castellotti P; Ferrarese M; Cirillo D; Barberis I; Bragazzi NL; Gazzaniga V; Ricucci V; Codecasa LR; Besozzi G; Martini M
    Tuberculosis (Edinb); 2020 Jul; 123():101948. PubMed ID: 32741532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Texas tuberculosis research symposium 2018: Research and clinical collaboration within the State of Texas - Moving towards elimination of TB.
    Dhandayuthapani S; Actor JK; Graviss EA
    Tuberculosis (Edinb); 2019 May; 116S():S1. PubMed ID: 31126719
    [No Abstract]   [Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
    Chae H; Shin SJ
    J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention.
    Lin MY; Ottenhoff TH
    Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):15-29. PubMed ID: 18393920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling biomarkers for tuberculosis control.
    Maertzdorf J; Weiner J; Kaufmann SH
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1140-8. PubMed ID: 22871324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in Africa: learning from pathogenesis for biomarker identification.
    Kaufmann SH; Parida SK
    Cell Host Microbe; 2008 Sep; 4(3):219-28. PubMed ID: 18779048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for TB treatment response: challenges and future strategies.
    Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
    J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis: current state of knowledge: an epilogue.
    Leung CC; Lange C; Zhang Y
    Respirology; 2013 Oct; 18(7):1047-55. PubMed ID: 23837600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
    Asalla S; Mohareer K; Banerjee S
    Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design.
    Singh G; Kumar A; Maan P; Kaur J
    Curr Drug Targets; 2017 Nov; 18(16):1904-1918. PubMed ID: 28699515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks.
    Tomioka H; Tatano Y; Sano C; Shimizu T
    J Infect Chemother; 2011 Jun; 17(3):302-17. PubMed ID: 21243398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonia caused by Mycobacterium tuberculosis.
    Wei M; Yongjie Zhao ; Zhuoyu Qian ; Biao Yang ; Xi J; Wei J; Tang B
    Microbes Infect; 2020; 22(6-7):278-284. PubMed ID: 32561408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the clinical pharmacology of tuberculosis medications.
    Egelund EF; Alsultan A; Peloquin CA
    Clin Pharmacol Ther; 2015 Oct; 98(4):387-93. PubMed ID: 26138226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of drug resistance in tuberculosis.
    Riska PF; Jacobs WR; Alland D
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S4-10. PubMed ID: 10688142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial biofilms: Understanding the genetic factors playing significant role in pathogenesis, resistance and diagnosis.
    Patel RR; Arun PP; Singh SK; Singh M
    Life Sci; 2024 Aug; 351():122778. PubMed ID: 38879157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.